Pharmacists at health system-based specialty pharmacies have the opportunity to improve patient care by providing comprehensive medication management for patients prescribed specialty medication. This manuscript describes how Vanderbilt Specialty Pharmacy integrated pharmacy services into existing outpatient specialty disease clinics at Vanderbilt University Medical Center, which improved patient access to therapy and continuity of care.

This study's findings indicate that access to DAAs in donor-derived HCV post-transplant is achievable and affordable; however, 35% of patients required an insurance appeal requiring significant administrative efforts. Additionally, patients not able to use the on-site specialty pharmacy and those requiring an insurance appeal were 5.8 and 5 times more likely to experience a delay in treatment initiation.

This study compared patient access to dalfampridine before versus after Vanderbilt Specialty Pharmacy obtained access to dispense the drug. Findings highlight that VSP can help more patients start treatment and start faster when limited distribution networks are removed.